JRSS Stock Overview
Develops and produces medical technology and equipment in the People’s Republic of China.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
JRSIS Health Care Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.40 |
| 52 Week High | US$0.90 |
| 52 Week Low | US$0.27 |
| Beta | 0.89 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | -6.49% |
| 33 Year Change | -89.95% |
| 5 Year Change | -99.48% |
| Change since IPO | -93.11% |
Recent News & Updates
Recent updates
Shareholder Returns
| JRSS | US Healthcare Services | US Market | |
|---|---|---|---|
| 7D | 0% | 0.3% | -2.9% |
| 1Y | -6.5% | -21.5% | 17.2% |
Return vs Industry: JRSS exceeded the US Healthcare Services industry which returned -21.5% over the past year.
Return vs Market: JRSS underperformed the US Market which returned 17.2% over the past year.
Price Volatility
| JRSS volatility | |
|---|---|
| JRSS Average Weekly Movement | n/a |
| Healthcare Services Industry Average Movement | 7.9% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 14.9% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: JRSS's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine JRSS's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2018 | 36 | Linhai Zhu | www.jhcc.cn |
JRSIS Health Care Corporation develops and produces medical technology and equipment in the People’s Republic of China. The company develops and markets a multi-faceted smart environment for the retail distribution of pharmaceutical products by pharmacies, hospitals, and online distributors. It offers JM-YF-2000 Automatic Medicine Dispenser, which provides intelligent prompts for high-speed facile human-computer interaction to yield prompt dispensing of medications and batch refilling in the user safety environment.
JRSIS Health Care Corporation Fundamentals Summary
| JRSS fundamental statistics | |
|---|---|
| Market cap | US$34.02m |
| Earnings (TTM) | -US$271.71k |
| Revenue (TTM) | US$3.49m |
9.8x
P/S Ratio-125.2x
P/E RatioIs JRSS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| JRSS income statement (TTM) | |
|---|---|
| Revenue | US$3.49m |
| Cost of Revenue | US$3.10m |
| Gross Profit | US$388.88k |
| Other Expenses | US$660.60k |
| Earnings | -US$271.71k |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.0032 |
| Gross Margin | 11.16% |
| Net Profit Margin | -7.80% |
| Debt/Equity Ratio | -459.3% |
How did JRSS perform over the long term?
See historical performance and comparison